Caribou Biosciences, INC. (CRBU) — 8-K Filings

8-K Filings (14)

• Caribou Biosciences Files 8-K — Mar 31, 2026 Risk: low
  On March 31, 2026, Caribou Biosciences, Inc. filed an 8-K report detailing events under Regulation FD Disclosure, Other Events, and Financial Statements/Exhibit
• Caribou Biosciences Files 8-K on Financials and Operations — Nov 3, 2025 Risk: medium
  Caribou Biosciences, Inc. filed an 8-K on November 3, 2025, reporting on its results of operations and financial condition. The filing also included disclosures
• Caribou Biosciences Files 8-K Report — Jun 23, 2025 Risk: low
  On June 18, 2025, Caribou Biosciences, Inc. filed an 8-K report. The filing indicates "Other Events" as the primary item of disclosure. No specific financial tr
• Caribou Biosciences Files 8-K on Shareholder Votes & Financials — Jun 13, 2025 Risk: low
  On June 12, 2025, Caribou Biosciences, Inc. filed an 8-K report detailing the submission of matters to a vote of security holders and financial statements. The
• Caribou Biosciences Files 8-K on Financials and Operations — Apr 24, 2025 Risk: medium
  On April 24, 2025, Caribou Biosciences, Inc. filed an 8-K report. The filing indicates the company is reporting on its results of operations and financial condi
• Caribou Biosciences Files 8-K — Jan 13, 2025 Risk: low
  On January 12, 2025, Caribou Biosciences, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits
• Caribou Biosciences Files 8-K on Officer/Director Changes — Jan 2, 2025 Risk: medium
  On January 2, 2025, Caribou Biosciences, Inc. filed an 8-K report. The filing primarily concerns the departure of directors or certain officers, the election of
• Caribou Biosciences Announces Board and Executive Changes — Sep 3, 2024 Risk: medium
  Caribou Biosciences, Inc. announced on September 1, 2024, changes in its board of directors and executive compensation arrangements. The filing details the depa
• Caribou Biosciences Files 8-K Report — Aug 12, 2024 Risk: low
  On August 12, 2024, Caribou Biosciences, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and other events, along with financia
• Caribou Biosciences Files 8-K on Operations and Finances — Jul 16, 2024 Risk: low
  On July 16, 2024, Caribou Biosciences, Inc. filed an 8-K report detailing results of operations and financial condition. The filing also covers costs associated
• Caribou Biosciences Files 8-K on Shareholder Vote & Financials — Jun 14, 2024 Risk: low
  On June 13, 2024, Caribou Biosciences, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders and financial statements. The co
• Caribou Biosciences (CRBU) Files 8-K Report — Jun 3, 2024 Risk: low
  On June 2, 2024, Caribou Biosciences, Inc. (CRBU) filed an 8-K report. The filing indicates the company's principal executive offices are located at 2929 7th St
• Caribou Biosciences Files 8-K Report — Apr 4, 2024 Risk: low
  On April 4, 2024, Caribou Biosciences, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, and other events, with no spec
• Caribou Biosciences Files Routine 8-K on Jan 7 Event — Jan 8, 2024
  Caribou Biosciences, Inc. filed an 8-K on January 8, 2024, reporting an event that occurred on January 7, 2024. This filing is a routine disclosure under Regula

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX